HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

GNC's Turnaround Moves Ahead On Email Addresses, Amazon Launch

This article was originally published in The Rose Sheet

Executive Summary

Email addresses for all customers joining its loyalty programs, reaching nearly 5.5m since the 2016 fourth quarter, and adding an Amazon storefront to its e-commerce business are key reasons behind the firm's confidence in its turnaround.

You may also be interested in...



GNC Digital Sales Hot But Shareholders Slow To Warm To China Expansion Deal

GNC’s Amazon storefront has an impact as the store and the firm’s website combine for 27% online sales growth in the first quarter. The firm delays a vote on a planned deal that would makes Harbin Pharmaceutical its largest shareholder, with a board voting bloc of five seats, and would launch a JV by the firms to expand GNC's presence in China.

Navigating Amazon: E-Commerce Giant Critical For OTC Drug Sales

As Amazon emerges as the leading search engine for information about consumer packaged goods products, OTC drug and other consumer health product firms should establish a presence, even if they expect not to sell much, says BeeKeeper consultancy's Lynn Graham.

Navigating Amazon: E-Commerce Giant Critical For OTC Drug Sales

As Amazon emerges as the leading search engine for information about consumer packaged goods products, OTC drug and other consumer health product firms should establish a presence, even if they expect not to sell much, says BeeKeeper consultancy's Lynn Graham.

Related Content

Topics

UsernamePublicRestriction

Register

RS109198

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel